The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.
Ingrid Amalia HavnesMarie Lindvik JørstadJim McVeighMarie-Claire Van HoutAstrid BjørnebekkPublished in: Substance abuse : research and treatment (2020)
Lifetime AAS use in this sample of SUD patients is common practice and comprise an underrecognized problem in SUD treatment. Given the deleterious implications to the individual and society that concomitant use of AAS may cause, it would be essential to raise the awareness about AAS use among SUD patients, and the level of competence among health professionals.